DJIA 17,776.12 -200.19 -1.11%
NASDAQ 4,900.89 -46.56 -0.94%
S&P 500 2,067.89 -18.35 -0.88%
market minute promo

Bayer AG (ADR) (NASDAQOTH: BAYRY)

150.27 -3.41 (-2.22%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BAYRY $150.27 -2.22%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $150.34
Previous Close $153.67
Daily Range $149.88 - $151.35
52-Week Range $124.36 - $156.77
Market Cap $124.3B
P/E Ratio 853.72
Dividend (Yield) $0.00 (1.4%)
Volume 55,338
Average Daily Volume 69,105
Current FY EPS $7.70

Sector

Healthcare

Industry

Pharma

Bayer AG (ADR) (BAYRY) Description

The Company offers products, including ethical pharmaceuticals and other health care products, agricultural products and polymers. Website:

News & Commentary Rss Feed

5 Freakishly Expensive Cancer Drugs

Prices for cancer medications are soaring.

Upcoming FDA Decisions We're Most Excited About

Three Motley Fool experts tell readers what upcoming FDA decisions have caught their eye.

Forget Gilead Sciences: Here Are 3 Better Biotech Stocks

Biogen Idec, Regeneron, and Amgen Inc. may be better bets than Gilead Sciences.

Regeneron Pharmaceuticals Inc. Earnings: All Eyes on Eylea

Regeneron reported its fourth-quarter and full-year numbers this morning. Here's what investors need to know.

This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market

Opthotech Corporation is researching a new therapy for wet-stage age-related macular degeneration that could have blockbuster potential.

3 Tech Giants Quietly Investing in Synthetic Biology

It's time for tech investors to acknowledge the potential of sneaky R&D projects in synthetic biology at Autodesk, Intel, and Microsoft.

Could These Tiny Biotech Stocks Double in 2015?

Ophthotech Corporation, Achillion Pharmaceuticals, and Portola Pharmaceuticals all have catalysts that could lift shares in 2015.

3 Reasons to Buy the iShares MSCI EAFE ETF

The iShares MSCI EAFE Exchange Traded Fund offers instant international diversification among top companies in top countries for a reasonably low overhead cost.

3 Biotech Stocks to Buy in December

Three Motley Fool analysts tell investors which biotechnology stocks are on their wish list this month.

This Could Be the Next Big Pharma Buyout

Three Motley Fool analysts tell investors which three companies they think would be ripe for an acquisition.

See More BAYRY News...

BAYRY's Top Competitors

BAYRY $150.27 (-2.22%)
Current stock: BAYRY
NVS $98.61 (-2.67%)
Current stock: NVS
RHHBY $34.38 (0.50%)
Current stock: RHHBY
PFE $34.79 (-0.60%)
Current stock: PFE